Search - tctmd.com

Displaying 461 - 480 of 925

Sort: Relevancy | Date

News Daily News

Study Suggests Noncardiac Surgery Can Be Safe as Early as 3 Months After PCI

Yael L. Maxwell

August 20, 2014

News Daily News

Meta-analysis Confirms Advantage of New-Generation DES in STEMI

Todd Neale

August 07, 2014

News Daily News

El Impacto Clínico del Fracaso del SLF Depende del Timing

L.A. McKeown

August 07, 2014

News Daily News

DES失效的临床影响取决于其发生时间

L.A. McKeown

August 07, 2014

News Daily News

Clinical Impact of DES Failure Depends on Timing

L.A. McKeown

August 07, 2014

News Industry News

STENTYS Reallocates Resources to focus on its Advanced Drug-Eluting Stent Program

July 31, 2014

News Industry News

Cook Medical's Zilver® PTX® Drug-Eluting Stent selected as a top emerging health technology in Canada

July 25, 2014

News Daily News

Bioresorbable Scaffold Performs Well, But Thrombosis Raises Concerns

Todd Neale

July 24, 2014

News Industry News

Boston Scientific Receives FDA Approval for REBEL™ Platinum Chromium Coronary Stent System

July 21, 2014

News Industry News

First patient enrollment in MASCOT registry represents major milestone for COMBO™ Dual Therapy Stent and OrbusNeich’s clinical program

July 16, 2014

News Daily News

HOST-ASSURE: Promus Element Noninferior to Resolute in All-Comers Population

July 10, 2014

News Daily News

SCAAR: Lower Risk of Early, Late Stent Thrombosis with Newer DES vs BMS in STEMI

Yael L. Maxwell

July 03, 2014

News Industry News

OrbusNeich Announces First Patient Enrollment in Physician-Initiated Study to Evaluate the Potential for Shorter-Term Dual Antiplatelet Therapy in ACS Patients

June 19, 2014

News Daily News

Un Panel Asesor de la FDA Aprueba un Balón recubierto de Paclitaxel para el Manejo de la Enfermedad Femoropoplítea

L.A. McKeown

June 17, 2014

News Industry News

Cook Medical makes Zilver® PTX® drug-eluting stent available in Canada

June 05, 2014

News Industry News

STENTYS to Acquire Stent Delivery Technology for Its Next-Generation of Self-Apposing Stents

June 04, 2014

News Daily News

Nationwide Registry Shows Trends in DES Use Over a Decade

June 02, 2014

News Daily News

Nobori BES Equals Promus Element in Long Lesions

Jason Kahn

May 30, 2014

News Daily News

El SLF Nobori es Similar al Promus Element en el Manejo de Lesiones Largas

Jason Kahn

May 30, 2014

News Daily News

ILLUMENATE First-in-Human Study: Novel Drug-Coated Balloon Yields Strong 2-Year Outcomes in SFA Lesions

May 30, 2014

Advertisement

Study Suggests Noncardiac Surgery Can Be Safe as Early as 3 Months After PCI

Meta-analysis Confirms Advantage of New-Generation DES in STEMI

El Impacto Clínico del Fracaso del SLF Depende del Timing

DES失效的临床影响取决于其发生时间

Clinical Impact of DES Failure Depends on Timing

STENTYS Reallocates Resources to focus on its Advanced Drug-Eluting Stent Program

Cook Medical's Zilver® PTX® Drug-Eluting Stent selected as a top emerging health technology in Canada

Bioresorbable Scaffold Performs Well, But Thrombosis Raises Concerns

Boston Scientific Receives FDA Approval for REBEL™ Platinum Chromium Coronary Stent System

First patient enrollment in MASCOT registry represents major milestone for COMBO™ Dual Therapy Stent and OrbusNeich’s clinical program

HOST-ASSURE: Promus Element Noninferior to Resolute in All-Comers Population

SCAAR: Lower Risk of Early, Late Stent Thrombosis with Newer DES vs BMS in STEMI

OrbusNeich Announces First Patient Enrollment in Physician-Initiated Study to Evaluate the Potential for Shorter-Term Dual Antiplatelet Therapy in ACS Patients

Un Panel Asesor de la FDA Aprueba un Balón recubierto de Paclitaxel para el Manejo de la Enfermedad Femoropoplítea

Cook Medical makes Zilver® PTX® drug-eluting stent available in Canada

STENTYS to Acquire Stent Delivery Technology for Its Next-Generation of Self-Apposing Stents

Nationwide Registry Shows Trends in DES Use Over a Decade

Nobori BES Equals Promus Element in Long Lesions

El SLF Nobori es Similar al Promus Element en el Manejo de Lesiones Largas

ILLUMENATE First-in-Human Study: Novel Drug-Coated Balloon Yields Strong 2-Year Outcomes in SFA Lesions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content